Skip to main content

Table 2 The relationship between personality traits and QoL. Note: the included studies by Petersen et al., Tomich et al., and Härtl et al., did not have any specific data and therefore could not be included in the table

From: A descriptive systematic review of the relationship between personality traits and quality of life of women with non-metastatic breast cancer

Personality traits

Correlation coefficient (r)

Variance in QoL explained by personality traits (%)

Odds ratio (CI)

 

Openness to Experience

Novelty seeking [13]

  

Overall QoL

8%*

  

Conscientiousness [1]

  

Overall QoL T3/BCT

9%**

  

Agency [19]

EWB

0.25*

    

IWB

0.10

    

Unmitigated agency [19]

EWB

-0.21

IWB

35%**

  

IWB

-0.38***

  

Extraversion

Optimism [14, 15]

NF

0.36***

  

EF (AD vs. MHI)

0.43 (0.30–0.65)***

PFE

0.37***

  

EF (AD vs. MHI)

0.69 (0.56–0.86)***

CF

0.15

  

SP

0.36***

  

SA

0.20*

  

F

0.22**

  

Agreeableness [1]

  

Overall QoL T3/BCT

4%*

  
  

Overall QoL T4/BCT

6%*

  

Neuroticism [1]

  

Overall QoL T2/MCT + 

19%***

  
  

Overall QoL T3/MTC + 

21%***

  
  

Overall QoL T4/MTC + 

20%***

  
  

Overall QoL T5/MTC + 

26%***

  
  

Overall QoL T5/BCT

34%***

  

Self-efficacy [18, 21]

Overall QoL

0.34*—0.49**

    

PWB

0.21—0.39**

    

SWB

0.24—0.27**

    

EWB

0.42**

    

FWB

0.27*—0.35**

    

Trait anxiety [1, 20, 23]

Overall QoL

-0.32*—-0.77**

Overall QoL T2/BCT

29%***

Overall QoL

7.81 (2.42–25.72) ***

PWB

-0.63**

Overall QoL T3/BCT

37%***

  

SWB

-0.50**

Overall QoL T4/BCT

43%***

  

EWB

-0.73**

    

FWB

-0.62**

    

PS

-0.33*

    
  1. Abbreviations: EWB Emotional Well-Being, IWB Interpersonal Well-Being, NF Negative Feelings, PFE Positive Feelings, CF Cognitive functioning, SP Sexual problems, SA Social Avoidance, F Fatigue, QoL Quality of Life, PWB Physical Well-Being, SWB Social/family Well-Being, FWB Functional Well-Being, PS Psychological/Spiritual, EF Emotional functioning, T2/3/4/5 Time measure point 2/3/4/5, BCT Breast-Conserving Therapy, MTC +  Mastectomy and MTC after BCT, AD Accelerated Decline, MHI Maintained High, MD Moderate Decline
  2. *p < 0.05; **p < 0.01; ***p < 0.001